← Eichor
Study identifier: NCT04390230 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ?

Condition: Surgery · Satisfaction · Penile Prosthesis; Complications  ·  Sponsor: Centre Hospitalier Universitaire de Nice

PhaseN/A
Planned participants120
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Sexual health and satisfaction are well know as critical critera to assess quality of life, at any age. Among the multiple aspects of sexual health, erectile dysfunction (ED) is not anymore a fate, mainly thanks to the advent of phosphodiesterase type 5 (PDE5) inhibitors in 1998. Nevertheless, a significant part of patients are intolerant or does not respond to PDE5 inhibitors and thus are looking for other treatment options. Since the first implantation of foreign material intracarvernosally in 1966 by Beheri, multiple modifications and enhancements were achieved in order to produce devices more reliable with a more natural appearance. First introduced in 1973 by Scott et al., inflatable prosthesis provides now high general satisfaction rates (69-94%), better than in malleable prostheses, except for few authors. In addition to changes in materials and construction, the two main manufacturers of IPP, Boston scientific AMS (Marlborough, MA, USA) and Coloplast (Minneapolis, MN, USA), modernized the pump mechanism of their devices. Since the introduction of AMS IPP, three main pump formats have been used : the standard pump has been replaced in 2004 by the " Tactile " pump and then the " Momentary Squeeze " (MS) pump in 2006, smaller and easier to deflate by not requiring the patient to hold the deflation button throughout deflation. Coloplast also replaced in 2008 their " Genesis " pump by a " One Touch Release " (OTR) pump, and finally in 2014 by the current " Touch " pump, …

This description comes directly from the study's public registry record.

Talk to the study team

Lionel MENDEL, MD  ·  00 33 (0)6 24 25 01 03  ·  mendel.l@chu-nice.fr

Aysha SHAIKH  ·  shaikh.a@chu-nice.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de NiceNice, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04390230